Neuroprotective Agents
Neuroprotective Agents is a class of pharmacological compounds that belong to the broader category of therapeutic agents used in neurodegenerative disease pharmacology, distinguished by their ability to slow, halt, or reverse neuronal damage and loss through mechanisms that mitigate neurotoxic, inflammatory, excitotoxic, or oxidative insults to the central nervous system.
11.8K
Publications
618.2K
Citations
53.8K
Authors
6.5K
Institutions
Publications per year
2017–2026
4.6K
Variants
NeuroprotectantsNeuroprotective Drugs
11.8K
1–5 of 11.8K
53.8K
Technion – Israel Institute of Technology, Israel
69 publications · 6.9K citations
46
h-index
29
h-index
28
h-index
27
h-index
26
h-index
1–5 of 53.8K
6.5K
Inserm
Paris, France
54 h-index
600 publications
40.9K citations
Universidad Complutense de Madrid
Madrid, Spain
53 h-index
431 publications
28.8K citations
National Institutes of Health
Bethesda, United States
52 h-index
333 publications
35.9K citations

Johns Hopkins University
Baltimore, United States
51 h-index
422 publications
45.2K citations
Harvard University
Cambridge, United States
49 h-index
346 publications
35.2K citations
Kyung Hee University
Seoul, South Korea
49 h-index
559 publications
29.5K citations
Seoul National University
Seoul, South Korea
47 h-index
351 publications
19.1K citations

Johns Hopkins Medicine
Baltimore, United States
47 h-index
318 publications
27.7K citations
1–8 of 6.5K
JNC · 252 publications · 21.5K citations
86
h-index
137 publications · 12.8K citations
75
h-index
97 publications · 17.2K citations
74
h-index
249 publications · 15.5K citations
72
h-index
219 publications · 12K citations
65
h-index
1–5